SCHEMBL24968792

SCHEMBL24968792

COCOc1ccc(Br)cc1COC(C)=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 3/20 0.45
CYP2D6 P10635 3/20 0.45
CYP2C19 P33261 3/20 0.45
CYP2C9 P11712 2/20 0.45
PTGDR2 Q9Y5Y4 2/20 0.44
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 3/20 0.41
TDP1 Q9NUW8 2/20 0.41
TSHR P16473 1/20 0.41
HIF1A Q16665 1/20 0.41
MEN1 O00255 4/20 0.39
KMT2A Q03164 4/20 0.39
PTGER1 P34995 4/20 0.39
CYP1A2 P05177 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
USP2 O75604 1/20 0.38
GAA P10253 1/20 0.38
THRB P10828 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30152325 1.00 CYP3A4 (0.45) CYP3A4CYP2D6CYP2C19CYP2C9PTGDR2
SCHEMBL3987965 0.82 CFD (0.46) CYP3A4PTGDR2ALDH1A1KDM4ETDP1
SCHEMBL5569933 0.80 PTGDR2 (0.45) CYP3A4CYP2D6CYP2C19CYP2C9PTGDR2
SCHEMBL8712221 0.79 PTGDR2 (0.59) CYP3A4CYP2D6CYP2C19CYP2C9PTGDR2
SCHEMBL30152364 0.79 PTGDR2 (0.59) CYP3A4CYP2D6CYP2C19CYP2C9PTGDR2
SCHEMBL28049660 0.77 ALDH1A1 (0.43) CYP3A4CYP2C9PTGDR2ALDH1A1KDM4E
SCHEMBL3328668 0.76 PTGDR2 (0.68) CYP3A4CYP2D6CYP2C19CYP2C9PTGDR2
SCHEMBL8712410 0.75 CCR5 (0.42) CYP3A4CYP2D6CYP2C19CYP2C9PTGDR2
SCHEMBL21713935 0.75 FFAR4 (0.44) CYP3A4PTGDR2ALDH1A1KDM4EMEN1
SCHEMBL20607703 0.75 XDH (0.40) CYP3A4CYP2D6CYP2C19CYP2C9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023009785-A1 TEAD INHIBITORS AND USES THEREOF CEDILLA THERAPEUTICS, INC. (US) 2023-02-02 WO disclosed